Mechanism of action
Ibuprofen reversibly inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes in a non-selective manner. COX enzymes catalyze the conversion of arachidonic acid to prostaglandin H2, the precursor of prostaglandins and thromboxanes.
COX-1 inhibition reduces constitutive prostaglandin production, which normally protects the gastric mucosa, maintains renal blood flow, and supports platelet function. This accounts for gastrointestinal toxicity, renal side effects, and antiplatelet activity.
COX-2 inhibition reduces inducible prostaglandin synthesis at sites of inflammation, providing the therapeutic anti-inflammatory, analgesic, and antipyretic effects. By decreasing prostaglandin E2 (PGE2) and prostaglandin I2 (PGI2), ibuprofen reduces pain mediator release, vascular permeability, and hypothalamic temperature set point.
Unlike aspirin, ibuprofen's inhibition is competitive and reversible, so COX enzyme activity returns as drug levels decline. The anti-platelet effect is therefore shorter-lived compared to aspirin's irreversible acetylation.
- Ibuprofen reversibly inhibits COX-1 and COX-2, reducing prostaglandin synthesis for analgesia, antipyresis, and anti-inflammation.
- Most serious adverse effect is gastrointestinal bleeding from COX-1 inhibition reducing protective gastric prostaglandins.
- Contraindicated in third trimester pregnancy due to risk of premature ductus arteriosus closure and oligohydramnios.
- NSAIDs including ibuprofen carry black box warnings for increased cardiovascular thrombotic events and serious GI adverse events.
- Ibuprofen reduces antihypertensive efficacy of ACE inhibitors, ARBs, and diuretics via prostaglandin inhibition and sodium retention.
- Triple whammy (NSAID + ACEI/ARB + diuretic) significantly increases acute kidney injury risk.
- Ibuprofen can interfere with aspirin's cardioprotective antiplatelet effect if taken before aspirin.
- Cross-reactivity exists in aspirin-exacerbated respiratory disease; patients with aspirin-induced asthma often react to ibuprofen.
Indications
Ibuprofen is indicated for a broad range of conditions:
- Mild to moderate pain: headache, dental pain, musculoskeletal pain, postoperative pain
- Fever reduction: antipyresis in children and adults
- Inflammatory conditions: osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis
- Primary dysmenorrhea: menstrual cramp relief via prostaglandin inhibition
- Patent ductus arteriosus (PDA): closure in premature neonates (intravenous formulation)
- Acute gout flares: alternative NSAID for symptomatic relief
- Pericarditis: adjunctive anti-inflammatory therapy
Ibuprofen is available over-the-counter for self-limited conditions and by prescription for chronic inflammatory diseases. It is one of the most commonly used analgesics worldwide due to its favorable efficacy and safety profile at appropriate doses.
Pharmacokinetics
Absorption: Rapidly absorbed from the gastrointestinal tract with peak plasma concentrations occurring 1–2 hours after oral administration. Food may delay absorption but does not significantly reduce bioavailability.
Distribution: Highly protein-bound (>99%), primarily to albumin. Volume of distribution is approximately 0.15 L/kg. It penetrates synovial fluid, reaching therapeutic concentrations in inflamed joints.
Metabolism: Extensively metabolized in the liver via oxidation and conjugation to inactive metabolites. CYP2C9 is the primary enzyme responsible for oxidative metabolism.
Excretion: Eliminated predominantly in urine (>90%) as metabolites and conjugates, with less than 1% excreted unchanged. The elimination half-life is approximately 2–4 hours in adults, necessitating multiple daily doses for sustained effect.
Special populations: Clearance may be reduced in elderly patients and those with renal or hepatic impairment, requiring dose adjustment or avoidance.
Adverse effects
Gastrointestinal
- Peptic ulcer disease and GI bleeding: COX-1 inhibition reduces protective gastric prostaglandins, increasing risk of erosions, ulcers, and hemorrhage (most serious adverse effect)
- Dyspepsia, nausea, abdominal pain, diarrhea
- Risk increases with higher doses, prolonged use, advanced age, concurrent corticosteroids, anticoagulants, or alcohol
Renal
- Acute kidney injury: prostaglandin inhibition reduces renal perfusion, particularly in volume-depleted states or pre-existing renal disease
- Sodium and water retention, leading to edema and hypertension
- Interstitial nephritis (rare)
- Hyperkalemia via reduced aldosterone secretion
Cardiovascular
- Increased risk of myocardial infarction and stroke, especially with prolonged use or high doses
- Hypertension and exacerbation of heart failure due to fluid retention
Hematologic
- Reversible inhibition of platelet aggregation, increasing bleeding risk (less pronounced than aspirin)
- Anemia secondary to chronic GI blood loss
Hypersensitivity
- NSAID-exacerbated respiratory disease (NERD): bronchospasm in aspirin-sensitive asthmatics
- Urticaria, angioedema, anaphylaxis (rare)
- Stevens-Johnson syndrome and toxic epidermal necrolysis (very rare)
Hepatic
- Transient elevation of liver enzymes
- Drug-induced liver injury (rare but can be severe)
Central nervous system
- Headache, dizziness, aseptic meningitis (rare, more common in SLE patients)
Contraindications and warnings
Absolute contraindications:
- Known hypersensitivity to ibuprofen, aspirin, or other NSAIDs
- History of NSAID-induced asthma, urticaria, or allergic reactions
- Active peptic ulcer disease or gastrointestinal bleeding
- Severe heart failure
- Third trimester of pregnancy (risk of premature closure of ductus arteriosus and oligohydramnios)
- Coronary artery bypass graft (CABG) surgery perioperative period
Warnings and precautions:
- Cardiovascular risk: Use the lowest effective dose for the shortest duration. Avoid in patients with recent MI or stroke.
- Gastrointestinal risk: Consider co-therapy with proton pump inhibitor in high-risk patients (age >65, history of ulcer, concurrent anticoagulants or corticosteroids).
- Renal impairment: Avoid or use with caution; monitor renal function, especially in elderly or volume-depleted patients.
- Hepatic impairment: Use with caution; monitor liver enzymes in chronic use.
- Asthma: Use cautiously in asthmatics; 10–20% of asthmatics have aspirin/NSAID sensitivity.
- Pregnancy: Avoid in third trimester. Use in first and second trimesters only if benefits outweigh risks.
- Anticoagulation: Increases bleeding risk when combined with warfarin, DOACs, or antiplatelet agents.
Black box warning (FDA): NSAIDs increase risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs also increase risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
Drug interactions
Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, DOACs): Increased bleeding risk due to additive antiplatelet effects and GI mucosal injury.
Antihypertensives (ACE inhibitors, ARBs, beta-blockers, diuretics): Reduced antihypertensive efficacy due to prostaglandin inhibition and sodium retention. ACE inhibitors and ARBs combined with ibuprofen increase acute kidney injury risk ("triple whammy" with diuretics).
Lithium: Ibuprofen reduces renal lithium clearance, increasing lithium levels and toxicity risk. Monitor lithium concentrations closely.
Methotrexate: NSAIDs reduce renal clearance of methotrexate, increasing toxicity risk, especially at high methotrexate doses.
Corticosteroids: Additive risk of gastrointestinal ulceration and bleeding.
SSRIs and SNRIs: Increased risk of upper GI bleeding due to serotonin-mediated effects on platelet function.
Aspirin: Ibuprofen may interfere with aspirin's irreversible antiplatelet effect when taken before aspirin. Patients on low-dose aspirin for cardioprotection should take aspirin at least 2 hours before ibuprofen or 8 hours after.
Cyclosporine and tacrolimus: Increased nephrotoxicity risk due to additive renal vasoconstriction.
Alcohol: Increases risk of gastrointestinal bleeding and hepatotoxicity.
Clinical pearls
- Ibuprofen is generally considered safer than other non-selective NSAIDs for cardiovascular risk when used short-term at low to moderate doses.
- For primary dysmenorrhea, ibuprofen is most effective when started at the onset of menses or just before, as it prevents prostaglandin formation rather than reversing existing inflammation.
- In children, ibuprofen and acetaminophen have similar antipyretic efficacy, but ibuprofen has a longer duration of action. Alternating the two is not routinely recommended due to dosing error risk.
- Ibuprofen can mask signs of infection (fever, inflammation), potentially delaying diagnosis of serious bacterial infections.
- Patients with aspirin-exacerbated respiratory disease (Samter's triad: asthma, nasal polyps, aspirin sensitivity) typically react to all non-selective NSAIDs including ibuprofen; selective COX-2 inhibitors may be tolerated.
- For osteoarthritis, topical ibuprofen formulations provide localized relief with lower systemic absorption and reduced GI/renal adverse effects compared to oral administration.
- Chronic ibuprofen use may impair bone healing after fractures by inhibiting prostaglandin-mediated osteoblast activity, though clinical significance remains debated.
- Ibuprofen is preferred over aspirin for PDA closure in neonates due to fewer bleeding complications.
- The "triple whammy" combination of NSAID + ACE inhibitor/ARB + diuretic significantly increases acute kidney injury risk, especially in elderly or volume-depleted patients.
NSAID adverse effects — RENAL: Renal impairment, Erosions/ulcers (GI), Nephritis (interstitial), Asthma exacerbation, Low platelet function
Practice questions
1. A 68-year-old man with osteoarthritis has been taking ibuprofen 600 mg three times daily for the past 6 months. He also takes lisinopril for hypertension and hydrochlorothiazide for mild edema. He presents with fatigue and is found to have a serum creatinine of 2.4 mg/dL (baseline 1.0 mg/dL). Urinalysis shows no protein or blood. Which of the following best explains his renal impairment?
2. A 32-year-old woman with asthma and nasal polyps develops severe bronchospasm and urticaria 30 minutes after taking ibuprofen for a headache. She has a similar history with aspirin. Which of the following medications is most likely to be safely tolerated?
3. A 45-year-old man is admitted for an acute anterior ST-elevation myocardial infarction and undergoes percutaneous coronary intervention with stent placement. He is started on aspirin 81 mg daily and clopidogrel. Two days later, he requests ibuprofen for back pain. What is the most appropriate recommendation?
Frequently asked questions
How does ibuprofen work?
Ibuprofen works by reversibly inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which prevents the conversion of arachidonic acid to prostaglandins. Prostaglandins mediate pain, fever, and inflammation, so blocking their synthesis provides analgesic, antipyretic, and anti-inflammatory effects. Unlike aspirin, ibuprofen's inhibition is competitive and reversible, meaning enzyme activity returns as the drug is cleared from the body.
What are the side effects of ibuprofen?
The most serious side effect is gastrointestinal bleeding and peptic ulcer disease due to reduced protective gastric prostaglandins. Other common adverse effects include dyspepsia, nausea, acute kidney injury (especially in volume-depleted states), sodium and water retention leading to edema and hypertension, and increased cardiovascular risk with prolonged use. Hypersensitivity reactions can include bronchospasm in aspirin-sensitive asthmatics and rarely anaphylaxis or severe skin reactions.
Is ibuprofen a controlled substance?
No, ibuprofen is not a controlled substance. It is a non-opioid analgesic available over-the-counter in lower strengths and by prescription in higher strengths. It does not have abuse potential or cause physical dependence, distinguishing it from opioid pain medications that are scheduled as controlled substances.
Can I take ibuprofen during pregnancy?
Ibuprofen should be avoided during pregnancy, especially in the third trimester. Use after 20 weeks gestation can cause fetal renal dysfunction leading to oligohydramnios, and use near delivery can cause premature closure of the fetal ductus arteriosus, leading to pulmonary hypertension. First and second trimester use should only occur if potential benefits justify the risks. Acetaminophen is generally preferred for pain and fever during pregnancy.
Ibuprofen vs acetaminophen — what is the difference?
Ibuprofen is an NSAID that inhibits COX enzymes, providing anti-inflammatory, analgesic, and antipyretic effects, while acetaminophen primarily provides analgesia and antipyresis with minimal anti-inflammatory activity. Ibuprofen has greater GI, renal, and cardiovascular risks, whereas acetaminophen's main concern is hepatotoxicity in overdose. Ibuprofen is more effective for inflammatory conditions like arthritis or dysmenorrhea, while acetaminophen is safer in pregnancy and for patients with GI or renal issues.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: C01EB16WHO ATC/DDD index: G02CC01
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.